Skip to main content

Published locations for Venetoclax plus ibrutinib appears to suit elderly and high-risk patients with CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Venetoclax plus ibrutinib appears to suit elderly and high-risk patients with CLL

User login

  • Reset your password
  • /content/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high-risk-patients-cll
  • /hematologynews/article/201783/cll/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high-risk
  • /oncologypractice/article/201783/cll/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high-risk
  • /hematology-oncology/article/201783/cll/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high-risk
  • /hematologytimes/article/201783/cll/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high-risk
  • /b-cell-lymphoma-icymi/article/201783/cll/venetoclax-plus-ibrutinib-appears-suit-elderly-and-high